Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia

Published:2018-01-23 Issue:5 Volume:180 Page:680-693
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lovisa Federica¹²,Zecca Marco³^ORCID,Rossi Bartolomeo¹²,Campeggio Mimma¹²,Magrin Elisa¹²⁴,Giarin Emanuela¹²,Buldini Barbara¹,Songia Simona⁵,Cazzaniga Giovanni⁵,Mina Tommaso³,Acquafredda Gloria³,Quarello Paola⁶,Locatelli Franco⁷⁸,Fagioli Franca⁶,Basso Giuseppe¹²

Affiliation:

1. Clinic of Paediatric Haemato-Oncology, Department of Women's and Children's Health; University of Padua; Padua Italy

2. Istituto di Ricerca Pediatrica Città della Speranza; Padua Italy

3. Paediatric Haematology/Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy

4. Departments of Biotherapy; Necker Children's Hospital; Assistance Publique-Hôpitaux de Paris; Paris France

5. Centro Ricerca Tettamanti; Paediatric Clinics; University of Milano-Bicocca; San Gerardo Hospital/Fondazione MBBM; Monza Italy

6. Paediatric Onco-Haematology; Stem Cell Transplantation and Cellular Therapy Division; Regina Margherita Children's Hospital; Turin Italy

7. Paediatric Haematology/Oncology; IRCCS Ospedale “Bambino Gesù”; Roma Italy

8. Department of Paediatric Sciences; University of Pavia; Pavia Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15086/fullpdf

Reference49 articles.

1. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group;Bader;Journal of Clinical Oncology,2009

2. Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial;Bader;Journal of Clinical Oncology,2015

3. The value of minimal residual disease (and diamonds);Balduzzi;Biology of Blood and Marrow Transplantation,2017

4. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study;Balduzzi;Lancet,2005

5. Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?;Balduzzi;British Journal of Haematology,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A STAT3 Degrader Demonstrates Pre-clinical Efficacy in Venetoclax resistant Acute Myeloid Leukemia;2024-08-07

2. Improving outcomes of hematopoietic stem cell transplant for leukemia in children and young adults in resource-limited setting;Pediatric Hematology Oncology Journal;2024-06

3. Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02;International Journal of Hematology;2023-06-26

4. Relapsed Acute Lymphoblastic Leukemia;Indian Journal of Pediatrics;2023-06-21

5. Multiparameter flow cytometry and ClonoSEQ correlation to evaluate precursor B-lymphoblastic leukemia measurable residual disease;Journal of Hematopathology;2023-04-14